Your shopping cart is currently empty

TLR9 antagonist1 (Compound 38) is a selective TLR9 inhibitor with an IC50 of 0.1 nM for hTLR9, demonstrating superior antagonistic activity compared to hTLR2/4/5/7/8. This compound exacerbates disease symptoms in mouse models of systemic lupus erythematosus (SLE) and raises levels of anti-dsDNA and anti-Sm antibodies. TLR9 antagonist1 is applicable in research on inflammatory and immune diseases such as lupus and arthritis.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | TLR9 antagonist1 (Compound 38) is a selective TLR9 inhibitor with an IC50 of 0.1 nM for hTLR9, demonstrating superior antagonistic activity compared to hTLR2/4/5/7/8. This compound exacerbates disease symptoms in mouse models of systemic lupus erythematosus (SLE) and raises levels of anti-dsDNA and anti-Sm antibodies. TLR9 antagonist1 is applicable in research on inflammatory and immune diseases such as lupus and arthritis. |
| Targets&IC50 | HEK/hTLR9:0.0001 μM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.